Rollins, Inc.
$17.22B- Market cap
- $16.71B
- Debt
- +$609.83M
- Cash
- −$100.00M
Capital structure 96% equity / 4% debt · EV / Revenue 4.58x · EV proxy / EBITDA proxy 20.24x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ROL stock price vs WELL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WELL's multiple
Needs WELL P/E.
Implied fair value · at ROL's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 96% equity / 4% debt · EV / Revenue 4.58x · EV proxy / EBITDA proxy 20.24x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROLLINS, INC. · implied price per share
Bear
$16.20
Base
$19.57
Bull
$24.12
WELLTOWER INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ECOLAB INC.
ROL vs ECL
HOME DEPOT, INC.
ROL vs HD
Serve Robotics Inc. /DE/
ROL vs SERV
CINTAS CORP
ROL vs CTAS
IRON MOUNTAIN INC
ROL vs IRM
MAXIMUS, INC.
ROL vs MMS
Ventas, Inc.
ROL vs VTR
OMEGA HEALTHCARE INVESTORS INC
ROL vs OHI
COSTAR GROUP, INC.
ROL vs CSGP
Prologis, Inc.
ROL vs PLD
Public Storage
ROL vs PSA
EQUITY RESIDENTIAL
ROL vs EQR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROL can sustain its current profitability and low-leverage profile while re-rating even modestly toward WELL multiples, then ROL looks attractive because its current price is far below WELL-implied value and its own historical trading band supports a much higher level than DCF does.
ROL trades far below WELL-implied value of $183.84, implying 384.2% upside versus the current price of $37.97. The gap is driven by WELL's much richer valuation multiples, especially P/E at 168.7x versus ROL at 34.8x and EV/EBITDA at 117.1x versus 22.2x.
Supporting Metrics